Drawing for TRIALVIEW

USPTO serial 97798498

TRIALVIEW

Reviewed by CopyMark Law Group

Reg. 8237981Status 700Registered
Filing date
Status date
Registration date
May 5, 2026
Examiner
YAO, GRETTA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRIALVIEW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joel D. Leviton

Joel D. Leviton STINSON LLP50 SOUTH SIXTH STREET, SUITE 2600MINNEAPOLIS, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable database management software in the fields of clinical and medical research and healthcare; downloadable computer application software for data analytics; downloadable computer application software for managing and verifying clinical trial patient data, clinical trial results and clinical trial regulatory submissions; downloadable computer software for managing and verifying clinical trial patient data, clinical trial results and clinical trial regulatory submissions; downloadable computer software for use in managing and conducting clinical trials; downloadable data analytics software for managing and conducting clinical trials; downloadable electronic reports in the field of clinical trials, medical research and healthcare; downloadable publications, namely, articles, case studies, reports, newsletters, surveys, guides, blogs, periodicals in the field of clinical trials and medical research; downloadable software for managing and conducting clinical trials, managing and verifying clinical trial patient data, clinical trial results and clinical trial regulatory submissions; downloadable software and application software for computers or mobile devices for managing and conducting clinical trials, managing and verifying clinical trial patient data, clinical trial results and clinical trial regulatory submissions in the fields of clinical and medical research and healthcareACTIVE—
035Data processing services; advertising, marketing and promotion services; advisory services for business management; advisory services relating to business analysis; business advisory services; business administration services in the fields of healthcare; business administration; business data analysis services; market research and business analysis; business consulting and management in the fields of clinical trials and healthcare; business data analytics; compilation, processing and analysis of statistics for business purposes; computerised market research; data processing, systematisation and management; database management; distribution of advertising, marketing and promotional materials; distribution of promotional matter; interpretation of market research data; market analysis and research services; market research and market analysis; market research consultancy; market research; marketing consulting servicesACTIVE—
041Education and instruction services, namely, arranging and conducting of seminars, workshops, classes and conferences in the fields of clinical trials, medical research and healthcare; education and training services, namely, arranging and conducting of educational conferences, workshops and programs and providing courses of instruction in the fields of clinical trials, medical research and healthcare; education services, namely providing classes, panel discussions, workshops and seminars in the fields of clinical trials, medical research and healthcare; providing online, non-downloadable electronic publications, namely, articles, case studies, reports, newsletters, surveys, guides, blogs, periodicals services in the fields of clinical trials, medical research and healthcare; training, namely, arranging and conducting of educational conferences, workshops and programs and providing courses of instruction and educational consultancy services in the fields of clinical trials, medical research and healthcareACTIVE—
042Scientific and medical research in the nature of conducting clinical trials for others; computer data analytics software consultancy; computer data analytics software development; computer programming in the fields of clinical trials, medical research and healthcare; advisory services relating to computer software; computerised data collection from clinical trial patients; computerised data storage; database design and development services; design, development and programming of data analytics software; design, development and programming of software and application software in the fields of clinical trials, medical research and healthcare; designing of data processing systems; document management for regulatory compliance during clinical trials; installation, maintenance, repair, integration, configuration, updating, programming and implementation of computer software; Platform as a Service (PaaS) services featuring software and application software for data collection, data management, data analytics, data analysis, communication and scheduling in the fields of clinical trials, medical research and healthcare; Platform as a Service (PaaS) services featuring software for managing and conducting clinical trials, managing and verifying clinical trial patient data, clinical trial results and clinical trial regulatory submissions; providing temporary use of online non-downloadable computer software for managing and verifying clinical trial patient data, clinical trial results and clinical trial regulatory submissions; providing temporary use of online non-downloadable software for use in clinical trials; remote monitoring of clinical trial patients; secure sharing of data collected from clinical trial patients; Software as a Service (SaaS) services featuring software and application software for data collection, data management, data analytics, data analysis, communication and scheduling in the fields of clinical and medical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 5, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 18, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 26, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 26, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 14, 2025GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 14, 2025GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 14, 2025CNSISUSPENSION INQUIRY WRITTEN—
Oct 8, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 7, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 7, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Apr 7, 2025CNSLSUSPENSION LETTER WRITTEN—
Apr 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 28, 2025ALIEASSIGNED TO LIE—
Mar 11, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 21, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 21, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 21, 2024CNSISUSPENSION INQUIRY WRITTEN—
Jan 25, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 25, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jan 25, 2024CNSLSUSPENSION LETTER WRITTEN—
Dec 29, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 15, 2023DOCKASSIGNED TO EXAMINER—
Mar 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 20, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance